Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis

Genomics

Volumn 83, Issue 1, 2004, Pages 1-8

  White, Jonathan Richard ^a   Harris, Robert A ^a   Lee, Sheena R ^a   Craigon, Marie H ^a   Binley, Katie ^a   Price, Toby ^a   Beard, Georgina L ^a   Mundy, Christopher R ^a   Naylor, S ^a  

^a OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENIC FACTOR; PROTEIN; PROTEOME; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ARTICLE; BLOOD FLOW; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE TRANSFER; GENETIC CODE; HUMAN; HUMAN CELL; HYPOXIA; MACROPHAGE; OXYGENATION; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 0345118952     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0888-7543(03)00215-5     Document Type: Article

References (45)

1. 2 tension. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514.
2. Wiesener M.S.et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood. 92:1998;2260-2268.
3. Wiesener M.S.et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 17:2003;271-273.
4. Lewis J.S., Lee J.A., Underwood J.C., Harris A.L., Lewis C.E. Macrophage responses to hypoxia: relevance to disease mechanisms. J. Leukocyte Biol. 66:1999;889-900.
5. Knighton D.R., Hunt T.K., Scheuenstuhl H., Halliday B.J., Werb Z., Banda M.J. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science. 221:1983;1283-1285.
6. Metinko A.P., Kunkel S.L., Standiford T.J., Strieter R.M. Anoxia-hyperoxia induces monocyte-derived interleukin-8. J. Clin. Invest. 90:1992;791-798.
7. Harmey J.H., Dimitriadis E., Kay E., Redmond H.P., Bouchier-Hayes D. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann. Surg. Oncol. 5:1998;271-278.
8. Kuwabara K.et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl. Acad. Sci. USA. 92:1995;4606-4610.
9. Leek R.D., Lewis C.E., Whitehouse R., Greenall M., Clarke J., Harris A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56:1996;4625-4629.
10. Talks K.L.et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157:2000;411-421.
11. Leek R.D.et al. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res. 62:2002;1326-1329.
12. Griffiths L.et al. The macrophage - a novel system to deliver gene therapy to pathological hypoxia. Gene Ther. 7:2000;255-262.
13. Boast K.et al. Characterization of physiologically regulated vectors for the treatment of ischemic disease. Hum. Gene Ther. 10:1999;2197-2208.
14. Patel B., Khaliq A., Jarvis-Evans J., McLeod D., Mackness M., Boulton M. Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. Biochem. Mol. Biol. Int. 34:1994;639-644.
15. Hartmann A.et al. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res. 59:1999;1578-1583.
16. Green C.J.et al. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res. 61:2001;2696-2703.
17. Sodhi C.P., Phadke S.A., Batlle D., Sahai A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes. 50:2001;1482-1490.
18. Griffiths L., Dachs G.U., Bicknell R., Harris A.L., Stratford I.J. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res. 57:1997;570-572.
19. Hill A.A., Hunter C.P., Tsung B.T., Tucker-Kellogg G., Brown E.L. Genomic analysis of gene expression in C. elegans. Science. 290:2000;809-812.
20. Suri C.et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
21. Zhu H.et al. Cloning of a novel gene, ANGPTL4 and the functional study in angiogenesis. Zhonghua Yi Xue Za Zhi. 82:2002;94-99.
22. Ishikawa T.et al. Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development. 128:2001;25-33.
23. Bell S.E.et al. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signalling. J. Cell Sci. 114:2001;2755-2773.
24. Raju K.S., Alessandri G., Ziche M., Gullino P.M. Ceruloplasmin, copper ions, and angiogenesis. J. Natl. Cancer Inst. 69:1982;1183-1188.
25. Ziche M., Jones J., Gullino P.M. Role of prostaglandin E1 and copper in angiogenesis. J. Natl. Cancer Inst. 69:1982;475-482.
26. Gullino P.M. Considerations on the mechanism of the angiogenic response. Anticancer Res. 6:1986;153-158.
27. Brem S.S., Zagzag D., Tsanaclis A.M., Gately S., Elkouby M.P., Brien S.E. Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am. J. Pathol. 137:1990;1121-1142.
28. Brem S., Tsanaclis A.M., Zagzag D. Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain. Neurosurgery. 26:1990;391-396.
29. Brewer G.J.et al. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clin. Cancer Res. 6:2000;1-10.
30. Miyazono K., Usuki K., Heldin C.H. Platelet-derived endothelial cell growth factor. Prog. Growth Factor Res. 3:1991;207-217.
31. Fett J.W.et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. 24:1985;5480-5486.
32. Donovan D., Brown N.J., Bishop E.T., Lewis C.E. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis. 4:2001;113-121.
33. Aizawa Y.et al. Cloning and expression of interleukin-18 binding protein. FEBS Lett. 445:1999;338-342.
34. Cao R., Farnebo J., Kurimoto M., Cao Y. Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J. 13:1999;2195-2202.
35. Coughlin C.M.et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101:1998;1441-1452.
36. Miao H.Q., Soker S., Feiner L., Alonso J.L., Raper J.A., Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146:1999;233-242.
37. Huminiecki L., Gorn M., Suchting S., Poulsom R., Bicknell R. Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics. 79:2002;547-552.
38. Fang W., Hartmann N., Chow D.T., Riegel A.T., Wellstein A. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J. Biol. Chem. 267:1992;25889-25897.
39. Cheng N., Brantley D.M., Chen J. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev. 13:2002;75-85.
40. Simonovic M., Gettins P.G., Volz K. Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor. Proc. Natl. Acad. Sci. USA. 98:2001;11131-11135.
41. Choudhuri R., Zhang H.T., Donnini S., Ziche M., Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 57:1997;1814-1819.
42. Terai Y., Abe M., Miyamoto K., Koike M., Yamasaki M., Ueda M., Ueki M., Sato Y. Vascular smooth muscle cell growth-promoting factor/F-spondin inhibits angiogenesis via the blockade of integrin alphavbeta3 on vascular endothelial cells. J. Cell. Physiol. 188:2001;394-402.
43. Rosen E.M.et al. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo. Symp. Soc. Exp. Biol. 47:1993;227-234.
44. Iruela-Arispe M.L., Bornstein P., Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;5026-5030.
45. Griffiths L.et al. The macrophage - a novel system to deliver gene therapy to pathological hypoxia. Gene Ther. 7:2000;255-262.